Monday, 21 Aug 2017

You are here

Concomitant Septic Arthritis and Crystalline Arthropathy

I joined a poster tour this morning on the topic of infections and was intrigued by an abstract titled, Coexistence of septic and crystal-induced arthritis: a diagnostic challenge (#0560, Y Garcia-Mira, et al).

The authors sought to describe the characteristics of patients with concurrent septic and crystal arthritis through a retrospective analysis of patients with the concomitant diagnoses between 1985-2015 at a university hospital in Spain.  

Out of 123 patients with septic arthritis, 20.3% (25) had concurrent crystalline arthritis. All patients had positive bacterial culture (blood and/or synovial fluid) and crystals in synovial fluid. The majority (68%) were males and average age was 67 years. Risk factors identified were diabetes in 24%, use of diuretics in 24%, and CKD in 16% including 2 on dialysis and 4 with history of kidney transplant. There was a delay to diagnosis on average of 14 days and the most commonly affected joint was the knee followed by the foot and hip.

As far as types of crystalline arthropathy, 60% had MUS, 20% CPPD and 8% hydroxyapatite. 32% had positive gram stain and 88% had positive synovial fluid culture. Blood cultures were positive in 32%. Surgical debridement was done in 32% and mortalitiy was 8%.

I found the 20% incidence of concurrent septic arthritis and crystal disease to be quite high, but nonetheless this is something to consider especially in elderly males with certain co-morbidities, and reminds us that synovial fluid should always be examined for crystals and infection.  

Add new comment

More Like This

The RheumNow Week in Review – 18 August 2017

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report includes new data on lupus survival, pediatric lupus guidelines from SHARE, room temperature storage of etanercept, over or under-testing by rheumatologists and failure of pain meds to treat pain.

The RheumNow Week in Review – 11 August 2017

The RheumNow Week in Review caps the week's news every Friday. Dr Jack Cush reviews the news, journal reports and important events from the past week in rheumatology.  This week's news highlights include new data on the incidence of arthritis, lag times in patient referral, criteria for referral and why/how weather change affects arthritis pain.

Criteria for Early Referrals from Primary Care

Early diagnosis and early intervention has been the mantra of all who manage musculoskeletal (MSK) diseases for decades. While the rules for referral may be clear to some, the lack of uniformity and promotion amongst primary care providers is less certain.

MSK Ultrasound Now Standard for Rheumatology Training

In the United States, musculoskeletal ultrasound (MSUS) in rheumatology has grown significantly in the last few decades. Ten years ago, more than half of rheumatology fellows had training or exposure to MSUS. A current survey of training programs shows that 94% provide MSUS training.

The RheumNow Week in Review – 4 August 2017

Dr. Jack Cush reviews new FDA decisions on sirukumab and tofacitinib as well as other news items from the past week on RheumNow.com.